The GLP is committed to full transparency. Download and review our Annual Report.

Genome sequencing reveals driving mutations behind common brain tumor

| January 23, 2013

The following is an excerpt.

Large-scale genomic sequencing has identified two DNA mutations that appear to drive about 15 percent of brain tumours known as meningiomas, a finding that could lead to the first effective drug treatments for the tumours, report scientists from Dana-Farber Cancer Institute and the Broad Institute.

View the original article here: Genomic Sequencing Reveals Mutant ‘Drivers’ of Common Brain Tumour

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend